Daniil Gataulin
Stock Analyst at Chardan Capital
(4.70)
# 161
Out of 5,142 analysts
122
Total ratings
58.56%
Success rate
37.73%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniil Gataulin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OTLK Outlook Therapeutics | Maintains: Neutral | $1 | $0.40 | +150.00% | 12 | Feb 18, 2026 | |
| OCUL Ocular Therapeutix | Maintains: Buy | $21 | $8.41 | +149.70% | 5 | Feb 18, 2026 | |
| RGNX REGENXBIO | Maintains: Buy | $52 → $50 | $7.94 | +529.72% | 16 | Feb 10, 2026 | |
| OCGN Ocugen | Maintains: Buy | $7 | $1.64 | +326.83% | 15 | Jan 20, 2026 | |
| ANNX Annexon | Initiates: Buy | $16 | $4.89 | +227.20% | 1 | Dec 23, 2025 | |
| KLRS Kalaris Therapeutics | Initiates: Buy | $19 | $10.77 | +76.42% | 1 | Dec 23, 2025 | |
| QURE uniQure | Maintains: Buy | $53 | $24.47 | +116.64% | 11 | Dec 4, 2025 | |
| FBRX Forte Biosciences | Maintains: Buy | $61 | $28.69 | +112.62% | 7 | Nov 17, 2025 | |
| KOD Kodiak Sciences | Maintains: Neutral | $14 | $26.68 | -47.53% | 4 | Nov 17, 2025 | |
| ZURA Zura Bio | Maintains: Buy | $10 | $6.53 | +53.14% | 3 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 | $7.54 | +364.19% | 7 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 | $3.45 | +160.87% | 3 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $51 | $28.65 | +78.01% | 9 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 | $4.64 | +223.28% | 7 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 | $1.04 | +284.62% | 8 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 | $17.07 | +58.17% | 12 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $220 | $0.54 | +40,792.19% | 1 | Mar 7, 2024 |
Outlook Therapeutics
Feb 18, 2026
Maintains: Neutral
Price Target: $1
Current: $0.40
Upside: +150.00%
Ocular Therapeutix
Feb 18, 2026
Maintains: Buy
Price Target: $21
Current: $8.41
Upside: +149.70%
REGENXBIO
Feb 10, 2026
Maintains: Buy
Price Target: $52 → $50
Current: $7.94
Upside: +529.72%
Ocugen
Jan 20, 2026
Maintains: Buy
Price Target: $7
Current: $1.64
Upside: +326.83%
Annexon
Dec 23, 2025
Initiates: Buy
Price Target: $16
Current: $4.89
Upside: +227.20%
Kalaris Therapeutics
Dec 23, 2025
Initiates: Buy
Price Target: $19
Current: $10.77
Upside: +76.42%
uniQure
Dec 4, 2025
Maintains: Buy
Price Target: $53
Current: $24.47
Upside: +116.64%
Forte Biosciences
Nov 17, 2025
Maintains: Buy
Price Target: $61
Current: $28.69
Upside: +112.62%
Kodiak Sciences
Nov 17, 2025
Maintains: Neutral
Price Target: $14
Current: $26.68
Upside: -47.53%
Zura Bio
Nov 14, 2025
Maintains: Buy
Price Target: $10
Current: $6.53
Upside: +53.14%
Nov 14, 2025
Maintains: Buy
Price Target: $35
Current: $7.54
Upside: +364.19%
Nov 13, 2025
Maintains: Buy
Price Target: $9
Current: $3.45
Upside: +160.87%
Nov 11, 2025
Maintains: Buy
Price Target: $51
Current: $28.65
Upside: +78.01%
Aug 11, 2025
Maintains: Buy
Price Target: $15
Current: $4.64
Upside: +223.28%
Aug 8, 2025
Maintains: Buy
Price Target: $4
Current: $1.04
Upside: +284.62%
Aug 7, 2025
Maintains: Buy
Price Target: $27
Current: $17.07
Upside: +58.17%
Mar 7, 2024
Maintains: Buy
Price Target: $220
Current: $0.54
Upside: +40,792.19%